ASSESSMENT OF THE SAFETY AND ABILITY OF A ONCE-A-DAY DOSE OF AN ORALLY INHALED MEDICINE [IE, GLYCOPYRROLATE INHALATION SOLUTION = GIS] TO IMPROVE AIRFLOW IN THE LUNGS WHEN DELIVERED WITH AN ELECTRONIC EFLOW NEBULIZER SYSTEM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD):